23 results on '"Barnhart, Kurt T."'
Search Results
2. Proteome-defined changes in cellular pathways for decidua and trophoblast tissues associated with location and viability of early-stage pregnancy.
- Author
-
Beer, Lynn A., Senapati, Suneeta, Sammel, Mary D., Barnhart, Kurt T., Schreiber, Courtney A., and Speicher, David W.
- Subjects
ECTOPIC pregnancy ,DECIDUA ,TROPHOBLAST ,MISCARRIAGE ,PREGNANCY complications ,PREGNANCY outcomes - Abstract
Background: In early pregnancy, differentiating between a normal intrauterine pregnancy (IUP) and abnormal gestations including early pregnancy loss (EPL) or ectopic pregnancy (EP) is a major clinical challenge when ultrasound is not yet diagnostic. Clinical treatments for these outcomes are drastically different making early, accurate diagnosis imperative. Hence, a greater understanding of the biological mechanisms involved in these early pregnancy complications could lead to new molecular diagnostics. Methods: Trophoblast and endometrial tissue was collected from consenting women having an IUP (n = 4), EPL (n = 4), or EP (n = 2). Samples were analyzed by LC–MS/MS followed by a label-free proteomics analysis in an exploratory study. For each tissue type, pairwise comparisons of different pregnancy outcomes (EPL vs. IUP and EP vs. IUP) were performed, and protein changes having a fold change ≥ 3 and a Student's t-test p-value ≤ 0.05 were defined as significant. Pathway and network classification tools were used to group significantly changing proteins based on their functional similarities. Results: A total of 4792 and 4757 proteins were identified in decidua and trophoblast proteomes. For decidua, 125 protein levels (2.6% of the proteome) were significantly different between EP and IUP, whereas EPL and IUP decidua were more similar with only 68 (1.4%) differences. For trophoblasts, there were 66 (1.4%) differences between EPL and IUP. However, the largest group of 344 differences (7.2%) was observed between EP and IUP trophoblasts. In both tissues, proteins associated with ECM remodeling, cell adhesion and metabolic pathways showed decreases in EP specimens compared with IUP and EPL. In trophoblasts, EP showed elevation of inflammatory and immune response pathways. Conclusions: Overall, differences between an EP and IUP are greater than the changes observed when comparing ongoing IUP and nonviable intrauterine pregnancies (EPL) in both decidua and trophoblast proteomes. Furthermore, differences between EP and IUP were much higher in the trophoblast than in the decidua. This observation is true for the total number of protein changes as well as the extent of changes in upstream regulators and related pathways. This suggests that biomarkers and mechanisms of trophoblast function may be the best predictors of early pregnancy location and viability. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Effects of preconception lifestyle intervention in infertile women with obesity: The FIT-PLESE randomized controlled trial.
- Author
-
Legro, Richard S., Hansen, Karl R., Diamond, Michael P., Steiner, Anne Z., Coutifaris, Christos, Cedars, Marcelle I., Hoeger, Kathleen M., Usadi, Rebecca, Johnstone, Erica B., Haisenleder, Daniel J., Wild, Robert A., Barnhart, Kurt T., Mersereau, Jennifer, Trussell, J. C., Krawetz, Stephen A., Kris-Etherton, Penny M., Sarwer, David B., Santoro, Nanette, Eisenberg, Esther, and Huang, Hao
- Subjects
INFERTILITY ,MISCARRIAGE ,OBESITY in women ,WEIGHT loss ,INDUCED ovulation ,FIRST trimester of pregnancy ,ACADEMIC medical centers ,WEIGHT in infancy - Abstract
Background: Women with obesity and infertility are counseled to lose weight prior to conception and infertility treatment to improve pregnancy rates and birth outcomes, although confirmatory evidence from randomized trials is lacking. We assessed whether a preconception intensive lifestyle intervention with acute weight loss is superior to a weight neutral intervention at achieving a healthy live birth.Methods and Findings: In this open-label, randomized controlled study (FIT-PLESE), 379 women with obesity (BMI ≥ 30 kg/m2) and unexplained infertility were randomly assigned in a 1:1 ratio to 2 preconception lifestyle modification groups lasting 16 weeks, between July 2015 and July 2018 (final follow-up September 2019) followed by infertility therapy. The primary outcome was the healthy live birth (term infant of normal weight without major anomalies) incidence. This was conducted at 9 academic health centers across the United States. The intensive group underwent increased physical activity and weight loss (target 7%) through meal replacements and medication (Orlistat) compared to a standard group with increased physical activity alone without weight loss. This was followed by standardized empiric infertility treatment consisting of 3 cycles of ovarian stimulation/intrauterine insemination. Outcomes of any resulting pregnancy were tracked. Among 191 women randomized to standard lifestyle group, 40 dropped out of the study before conception; among 188 women randomized to intensive lifestyle group, 31 dropped out of the study before conception. All the randomized women were included in the intent-to-treat analysis for primary outcome of a healthy live birth. There were no significant differences in the incidence of healthy live births [standard 29/191(15.2%), intensive 23/188(12.2%), rate ratio 0.81 (0.48 to 1.34), P = 0.40]. Intensive had significant weight loss compared to standard (-6.6 ± 5.4% versus -0.3 ± 3.2%, P < 0.001). There were improvements in metabolic health, including a marked decrease in incidence of the metabolic syndrome (baseline to 16 weeks: standard: 53.6% to 49.4%, intensive 52.8% to 32.2%, P = 0.003). Gastrointestinal side effects were significantly more common in intensive. There was a higher, but nonsignificant, first trimester pregnancy loss in the intensive group (33.3% versus 23.7% in standard, 95% rate ratio 1.40, 95% confidence interval [CI]: 0.79 to 2.50). The main limitations of the study are the limited power of the study to detect rare complications and the design difficulty in finding an adequate time matched control intervention, as the standard exercise intervention may have potentially been helpful or harmful.Conclusions: A preconception intensive lifestyle intervention for weight loss did not improve fertility or birth outcomes compared to an exercise intervention without targeted weight loss. Improvement in metabolic health may not translate into improved female fecundity.Trial Registration: ClinicalTrials.gov NCT02432209. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
4. Effect of an Active vs Expectant Management Strategy on Successful Resolution of Pregnancy Among Patients With a Persisting Pregnancy of Unknown Location: The ACT or NOT Randomized Clinical Trial.
- Author
-
Barnhart, Kurt T., Hansen, Karl R., Stephenson, Mary D., Usadi, Rebecca, Steiner, Anne Z., Cedars, Marcelle I., Jungheim, Emily S., Hoeger, Kathleen M., Krawetz, Stephen A., Mills, Benjie, Alston, Meredith, Coutifaris, Christos, Senapati, Suneeta, Sonalkar, Sarita, Diamond, Michael P., Wild, Robert A., Rosen, Mitchell, Sammel, Mary D., Santoro, Nanette, and Eisenberg, Esther
- Subjects
- *
PREGNANCY complications , *ECTOPIC pregnancy , *METHOTREXATE , *CLINICAL trials , *PREGNANCY , *EVALUATION of medical care , *UTERINE hemorrhage , *RESEARCH , *DILATATION & curettage , *MISCARRIAGE , *RESEARCH methodology , *PATIENT satisfaction , *MEDICAL cooperation , *EVALUATION research , *ABORTIFACIENTS , *COMPARATIVE studies , *RANDOMIZED controlled trials , *RESEARCH funding , *COMBINED modality therapy , *FETAL ultrasonic imaging , *CHORIONIC gonadotropins - Abstract
Importance: Women with an early nonviable pregnancy of unknown location are at high risk of ectopic pregnancy and its inherent morbidity and mortality. Successful and timely resolution of the gestation, while minimizing unscheduled interventions, are important priorities.Objective: To determine if active management is more effective in achieving pregnancy resolution than expectant management and whether the use of empirical methotrexate is noninferior to uterine evacuation followed by methotrexate if needed.Design, Setting, and Participants: This multicenter randomized clinical trial recruited 255 hemodynamically stable women with a diagnosed persisting pregnancy of unknown location between July 25, 2014, and June 4, 2019, in 12 medical centers in the United States (final follow up, August 19, 2019).Interventions: Eligible patients were randomized in a 1:1:1 ratio to expectant management (n = 86), active management with uterine evacuation followed by methotrexate if needed (n = 87), or active management with empirical methotrexate using a 2-dose protocol (n = 82).Main Outcomes and Measures: The primary outcome was successful resolution of the pregnancy without change from initial strategy. The primary hypothesis tested for superiority of the active groups combined vs expectant management, and a secondary hypothesis tested for noninferiority of empirical methotrexate compared with uterine evacuation with methotrexate as needed using a noninferiority margin of -12%.Results: Among 255 patients who were randomized (median age, 31 years; interquartile range, 27-36 years), 253 (99.2%) completed the trial. Ninety-nine patients (39%) declined their randomized allocation (26.7% declined expectant management, 48.3% declined uterine evacuation, and 41.5% declined empirical methotrexate) and crossed over to a different group. Compared with patients randomized to receive expectant management (n = 86), women randomized to receive active management (n = 169) were significantly more likely to experience successful pregnancy resolution without change in their initial management strategy (51.5% vs 36.0%; difference, 15.4% [95% CI, 2.8% to 28.1%]; rate ratio, 1.43 [95% CI, 1.04 to 1.96]). Among active management strategies, empirical methotrexate was noninferior to uterine evacuation followed by methotrexate if needed with regard to successful pregnancy resolution without change in management strategy (54.9% vs 48.3%; difference, 6.6% [1-sided 97.5% CI, -8.4% to ∞]). The most common adverse event was vaginal bleeding for all of the 3 management groups (44.2%-52.9%).Conclusions and Relevance: Among patients with a persisting pregnancy of unknown location, patients randomized to receive active management, compared with those randomized to receive expectant management, more frequently achieved successful pregnancy resolution without change from the initial management strategy. The substantial crossover between groups should be considered when interpreting the results.Trial Registration: ClinicalTrials.gov Identifier: NCT02152696. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
5. Evaluation of a New Model for Human Chorionic Gonadotropin Rise in Pregnancies of Unknown Viability.
- Author
-
Bollig, Kassie J., Finlinson, Alex, Barnhart, Kurt T., Coutifaris, Christos, and Schust, Danny J.
- Subjects
- *
CHORIONIC gonadotropins , *MISCARRIAGE , *ECTOPIC pregnancy , *PREGNANCY - Abstract
The proposed human chorionic gonadotropin threshold model optimizes the balance between identifying viable intrauterine pregnancies and minimizing rates of misdiagnosis of nonviable pregnancies. OBJECTIVE: To evaluate the performance of a new human chorionic gonadotropin (hCG) threshold model to classify pregnancies as viable or nonviable using a longitudinal cohort of individuals with pregnancy of unknown viability. The secondary objective was to compare the new model with three established models. METHODS: This is a single-center, retrospective cohort study of individuals seen at the University of Missouri from January 1, 2015, until March 1, 2020, who had at least two consecutive quantitative hCG serum levels with an initial level greater than 2 milli-international units/mL and 5,000 milli-international units/mL or less, with the first interval between laboratory draws no greater than 7 days. Prevalence of correct classification of viable intrauterine pregnancies, ectopic pregnancies, and early pregnancy losses was evaluated with a new proposed hCG threshold model and compared with three established models describing minimum expected rates of hCG rise for a viable intrauterine pregnancy. RESULTS: Of an initial cohort of 1,295 individuals, 688 patients met inclusion criteria. One hundred sixty-seven individuals (24.3%) had a viable intrauterine pregnancy; 463 (67.3%) had an early pregnancy loss; and 58 (8.4%) had an ectopic pregnancy. A new model based on the total additive percent rise of hCG at 4 and 6 days after initial hCG (70% or greater and 200% or greater rise, respectively) was created. The new model was able to correctly identify 100% of viable intrauterine pregnancies while minimizing incorrect classification of early pregnancy losses and ectopic pregnancies as normal pregnancies. At 4 days after initial hCG, 14 ectopic pregnancies (24.1%) and 44 early pregnancy losses (9.5%) were incorrectly classified as potentially normal pregnancies. At 6 days after initial hCG, only seven ectopic pregnancies (12.1%) and 25 early pregnancy losses (5.6%) were incorrectly classified as potentially normal pregnancies. In established models, up to nine intrauterine pregnancies (5.4%) were misclassified as abnormal pregnancies and up to 26 ectopic pregnancies (44.8%) and 58 early pregnancy losses (12.5%) were incorrectly classified as potentially normal pregnancies. CONCLUSION: The proposed new hCG threshold model optimizes a balance between identifying potentially viable intrauterine pregnancies and minimizing misdiagnosis of ectopic pregnancies and early pregnancy losses. External validation in other cohorts is needed before widespread clinical use. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Declaring a gestation nonviable: when 99% certainty is not enough.
- Author
-
Barnhart, Kurt T., Senapati, Suneeta, and Sammel, Mary D.
- Subjects
ECTOPIC pregnancy ,PREGNANCY ,ABORTION ,PREGNANCY outcomes ,PRENATAL care ,CLINICAL prediction rules ,REFERENCE values ,MISCARRIAGE ,UNCERTAINTY ,CHORIONIC gonadotropins ,FETAL ultrasonic imaging - Published
- 2021
- Full Text
- View/download PDF
7. The incidence and importance of the pseudogestational sac revisited.
- Author
-
Lee, Iris T., Rubin, Elizabeth S., Wu, Jessica, Koelper, Nathanael, and Barnhart, Kurt T.
- Subjects
ECTOPIC pregnancy ,MISCARRIAGE ,DELAYED diagnosis ,UTERINE hemorrhage ,PELVIC pain ,ABDOMINAL pain ,ULTRASONIC imaging ,RETROSPECTIVE studies ,DISEASE incidence ,HUMAN embryology - Abstract
Background: In a pregnancy of unknown location, an intrauterine fluid collection may represent either the early gestational sac of an intrauterine pregnancy, or as reported in previous literature, the pseudogestational sac of an ectopic pregnancy. Various sonographic features have been used to distinguish these 2 entities, but the clinical relevance of the pseudogestational sac remains unclear.Objective: To establish the incidence and relative rate of intrauterine fluid collection among ectopic and intrauterine pregnancies and to determine if the size of the collection differs between ectopic and intrauterine pregnancies STUDY DESIGN: We performed a retrospective cohort study of women with pregnancies of unknown location and pelvic or abdominal pain or bleeding. We calculated the incidences of intrauterine fluid collections among ectopic and intrauterine pregnancies, including both ongoing pregnancies and spontaneous abortions, given that that our focus was location and not viability. We calculated the relative risk of ectopic pregnancy if an intrauterine fluid collection was present, adjusting for age and vaginal bleeding. We compared the incidences of ectopic and intrauterine pregnancies among those with and without intrauterine fluid collections. Among those with collections, we compared the mean sac diameter between ectopic and intrauterine pregnancies in continuous and categorical fashions.Results: We evaluated 1236 women presenting with a pregnancy of unknown location. The rates of ectopic and intrauterine pregnancies (including spontaneous abortions) were 13.1% and 63.9%, respectively, with the remainder lost to follow-up. On ultrasound, 452 women (36.6%) had an intrauterine fluid collection. Eight of 162 ectopic pregnancies (4.9%) had a collection, compared with 363 of 789 intrauterine pregnancies (46.0%) (P=.01). Of the ectopics with a fluid collection, 5 had an adnexal mass. The presence of intrauterine fluid collection decreased the risk of ectopic pregnancy (adjusted relative risk, 0.09; 95% confidence interval, 0.05-0.19) after adjusting for age and the presence of bleeding. Among those with an intrauterine fluid collection, the rate of ectopic pregnancy was 2.2%, and the rate of intrauterine pregnancy was 97.8%; among those without a collection, the rate of ectopic pregnancy was 26.7%, and the rate of intrauterine pregnancy was 73.3%. The mean sac diameter did not differ between ectopic and intrauterine pregnancies, whether analyzed continuously or categorically.Conclusion: In the presence of an intrauterine fluid collection, the rate of ectopic pregnancy is very low. The size of the intrauterine fluid collection in a woman with a pregnancy of unknown location cannot be used to distinguish between a gestational sac and a pseudogestational sac. Pseudogestational sacs are uncommon and of little clinical consequence. In assessing pregnancies of unknown location, clinicians should incorporate the entire clinical picture, including other sonographic findings, to avoid incorrect or delayed diagnoses. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
8. Early pregnancy failure: beware of the pitfalls of modern management
- Author
-
Barnhart, Kurt T.
- Subjects
- *
PREGNANT women , *METHOTREXATE , *ECTOPIC pregnancy , *LITERATURE reviews , *PRENATAL diagnosis , *DIAGNOSIS ,TREATMENT of pregnancy complications - Abstract
The evolution of the diagnosis and management of women with an early pregnancy loss has been a success story. The mortality from ectopic pregnancy has objectively been decreased in the past few decades. However, modern management has resulted in a new set of issues. Over-interpretation of a single ultrasound, misunderstanding of the utility of serial hCG values, and inappropriate use of methotrexate can result in iatrogenic complications. Modern management has successfully improved the diagnosis of ectopic pregnancy before rupture; it should now also focus on ensuring that an intrauterine pregnancy is not interrupted as a result of diagnosis and treatment. This article reviews some of the pitfalls of the modern management of early pregnancy failure and introduces a series of articles on the subject. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
9. Symptomatic Patients With an Early Viable Intrauterine Pregnancy: hCG Curves Redefined.
- Author
-
Barnhart, Kurt T., Sammel, Mary D., Rinaudo, Paolo F., Lan Zhou, Hummel, Amy C., and Wensheng Guo
- Subjects
- *
CHORIONIC gonadotropins , *PREGNANCY , *MENSTRUATION , *MISCARRIAGE , *ECTOPIC pregnancy , *PREGNANCY complications - Abstract
OBJECTIVE: To analyze the change in serial human chorionic gonadotropin (hCG) levels in women symptomatic with pain or bleeding who presented with nondiagnostic ultrasonography but were ultimately confirmed to have a viable intrauterine pregnancy. METHODS: The rise in serial hCG measures were modeled over time, with the start point defined in 2 ways: by last menstrual period and by date of presentation for care. Both semiparametric (spline) curves and linear random-effects models were explored. The slope and projected increase of hCG were calculated to define 99% of viable intrauterine pregnancies. RESULTS: A total of 287 subjects met inclusion criteria and contributed 861 measurements of hCG. On average, these subjects contributed 3.00 observations and were followed up for 5.25 days. A linear increase in log hCG best described the pattern of rise. Curves derived from last menstrual period and day of presentation do not differ substantially. The median slope for a rise of hCG after 1 day was 1.50, (or a 50% increase); 2.24 after 2 days (or a 124% rise), and 5.00 after 4 days. The fastest rise was 1.81 at 1 day, 3.28 at 2 days, and 10.76 at 4 days. The slowest or minimal rise for a normal viable intrauterine pregnancy was 24% at 1 day and 53% at 2 days. CONCLUSION: These data define the slowest rise in serial hCG values for a potentially viable gestation and will aid in distinguishing a viable early pregnancy from a miscarriage or ectopic pregnancy. The minimal rise in serial hCG values for women with a viable intrauterine pregnancy is ‘slower’ than previously reported, suggesting that intervention to diagnosis and treat an abnormal gestation should be more conservative. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
10. Hormone pattern after misoprostol administration for a nonviable first-trimester gestation
- Author
-
Barnhart, Kurt T., Bader, Thomas, Huang, Xiangke, Frederick, Margaret M., Timbers, Kelly A., and Zhang, Jun Jim
- Subjects
- *
PREGNANCY , *MISCARRIAGE , *SEX hormones , *HORMONE therapy , *LOGISTIC regression analysis - Abstract
: ObjectiveTo evaluate serial hormone concentrations in subjects treated with vaginally administered misoprostol for early pregnancy failure.: DesignAs part of a randomized clinical trial, serum was collected on treatment days 1, 3, 8, and 15.: SettingMulticenter clinical trial.: Patient(s)Women with a nonviable first-trimester pregnancy.: Intervention(s)Serum concentrations of human chorionic gonadotropin (hCG), progesterone, and sex hormone binding globulin (SHBG) were evaluated.: Main outcome measure(s)A logistic regression model was constructed to assess the associations of percent and complete expulsion of the gestational sac and/or successful management.: Result(s)The percent change from the day of treatment until the first follow-up visit was predictive for complete expulsion for progesterone (P) (P<.005) and hCG (P<.005), but not for SHBG. The actual value was not significantly associated with complete expulsion or successful management. A decrease (day 1–3) of 79% for both hCG and P was associated with a 90% probability of complete passage of the gestational sac. A 90% probability of successful management was noted if P decreased by 78% on day 3 or 59% on day 7, or hCG decreased by 74% on day 3 or 78% on day 7 compared with pretreatment values.: Conclusion(s)Percent change, but not absolute change, in serial hormone values are strongly associated with both the complete expulsion of the gestational sac with one dose of misoprostol and ultimate success. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
11. Usefulness of pipelle endometrial biopsy in the diagnosis of women at risk for ectopic pregnancy.
- Author
-
Barnhart, Kurt T., Gracia, Clarisa R., Reindl, Beth, and Wheeler, James E.
- Subjects
BIOPSY ,ECTOPIC pregnancy ,CHORIONIC villi ,CLINICAL trials ,COMPARATIVE studies ,ENDOMETRIUM ,FROZEN tissue sections ,RESEARCH methodology ,MEDICAL cooperation ,MISCARRIAGE ,RESEARCH ,EVALUATION research ,RANDOMIZED controlled trials ,PREDICTIVE tests ,BLIND experiment - Abstract
Objective: The purpose of this study was to determine the accuracy of endometrial Pipelle (Unimar) biopsy to detect chorionic villi in suspected ectopic pregnancy.Study Design: This was a blinded prospective trial that involved 32 women who were in stable condition with suspected ectopic pregnancy. Endometrial pipelle sampling was performed before uterine dilation and curettage. Pipelle and frozen section results were compared with final disease.Results: Ten of 32 patients (31%) had chorionic villi that was consistent with a miscarriage; 22 of 32 patients (69%) had none detected. Pipelle biopsy had a sensitivity of 30% (95% CI, 6.7-65.2), a specificity of 100% (95% CI, 84.5-100), a positive predictive value of 100% (95% CI, 29.2-100), and a negative predictive value of 76% (95% CI, 56.5-87). Frozen section had a sensitivity of 87.5% (95% CI, 47.3-99.7), a specificity of 100% (95% CI, 83.1-100), a positive predictive value of 100% (95% CI, 59-100), and a negative predictive value of 95.3% (95% CI, 76.1-99.8).Conclusion: In patients with suspected ectopic pregnancy, Pipelle sampling is not a substitute for curettage because the sensitivity and predictive values are unacceptable. [ABSTRACT FROM AUTHOR]- Published
- 2003
- Full Text
- View/download PDF
12. Fresh vs. frozen embryo transfer: new approach to minimize the limitations of using national surveillance data for clinical research.
- Author
-
Weiss, Marissa Steinberg, Luo, Chongliang, Zhang, Yujia, Chen, Yong, Kissin, Dmitry M., Satten, Glen A., and Barnhart, Kurt T.
- Subjects
- *
EMBRYO transfer , *MEDICAL research , *SMALL for gestational age , *REPRODUCTIVE technology , *MISCARRIAGE - Abstract
To assess the benefit of frozen vs. fresh elective single embryo transfer using traditional and novel methods of controlling for confounding. Retrospective cohort study using data from the National Assisted Reproductive Technology Surveillance System. Not applicable. A total of 44,750 women aged 20–35 years undergoing their first lifetime oocyte retrieval and embryo transfer in 2016–2017, who had ≥4 embryos cryopreserved. Fresh elective single embryo transfer and frozen elective single embryo transfer. The primary outcome was a singleton live birth. Secondary outcomes included rates of total live birth (singleton plus multiple gestations), twin live birth, clinical intrauterine gestation, total pregnancy loss, biochemical pregnancy, and ectopic pregnancy. Outcomes for infants included gestational age at delivery, birth weight, and being small for gestational age. The eligibility criteria were met by 6,324 fresh and 2,318 frozen cycles. Patients undergoing fresh and frozen transfer had comparable mean age (30.69 [standard deviation {SD} 0.08] years vs. 31.06 [SD 0.08] years) and body mass index (24.76 [SD 0.20] vs. 25.65 [SD 0.15]); however, women in the frozen cohort created more embryos (8.1 [SD 0.12] vs. 6.8 [SD 0.08]). Singleton live birth rates in the fresh vs. frozen groups were 51.4% vs. 48.8% (risk ratio 1.05; 95% confidence interval [CI], 1.00–1.10). After adjustment with a log-linear regression model and propensity score analysis, the difference in singleton live birth rates remained nonsignificant (adjusted risk ratio, 1.05; 95% CI, 0.97–1.14 and 1.02; 95% CI, 0.96–1.08, respectively). A novel dynamical model confirmed inherent fertility (probability of ever achieving a pregnancy) was balanced between groups (odds ratio, 1.23; 95% CI 0.78–1.95]). The per-cycle probability of singleton live birth was not different between groups (odds ratio 1.11 [95% CI 0.94–1.3]). In this retrospective cohort study of fresh vs. frozen elective single embryo transfer, there was no statistically significant difference in singleton live birth rate after adjustment using log-linear models and propensity score analysis. The successful application of a novel dynamical model, which incorporates multiple assisted reproductive technology cycles from the same woman as a surrogate for inherent fertility, offers a novel and complementary perspective for assessing interventions using national surveillance data. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Utility of dilation and curettage in the diagnosis of pregnancy of unknown location.
- Author
-
Shaunik, Alka, Kulp, Jennifer, Appleby, Dina H., Sammel, Mary D., and Barnhart, Kurt T.
- Subjects
PREGNANCY complications ,DILATATION & extraction abortion ,CURETTAGE ,ECTOPIC pregnancy ,COHORT analysis ,DISEASE prevalence ,MISCARRIAGE ,CHORIONIC gonadotropins ,MEDICAL statistics ,DIAGNOSIS - Abstract
Objective: We sought to determine utility of uterine evacuation for diagnosis of nonviable pregnancy of unknown location (PUL). Study Design: We conducted a cohort study to assess the prevalence of ectopic pregnancy (EP), overall, and stratified by presenting signs and symptoms in women with a nonviable PUL. Results: Of the 173 women, 66 (38%) had miscarriage (spontaneous abortion [SAB]) and 107 (62%) had EP. When initial human chorionic gonadotropin (hCG) was <2000 mIU/mL, the odds of an EP were greater (odds ratio, 4.32; 95% confidence interval, 2.04–9.12). Demographic factors, obstetric history, and clinical presentation were not useful in distinguishing between EP and SAB. Pre-evacuation hCG increase had strong trend association with EP (odds ratio, 2.14; 95% confidence interval, 0.98–4.68). A >30% fall in postcurettage hCG was suggestive, but was not a diagnostic indicator of SAB. Conclusion: Uterine evacuation is a useful diagnostic aid for women with nonviable PUL. Nondiagnostic ultrasound findings and absolute and serial hCG values are associated with, but do not accurately predict final diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
14. BhCG doubling time in early gestation in symptomatic patients with an intrauterine pregnancy: the curves redefined.
- Author
-
Barnhart, Kurt T., Rinaudo, Paolo F., Sammel, Mary D., Zhou, Lan, Guo, Wenshang, and Hummel, Amy
- Subjects
- *
CHORIONIC gonadotropins , *PREGNANCY , *EMERGENCY medical services , *MENSTRUAL cycle , *MISCARRIAGE - Published
- 2003
- Full Text
- View/download PDF
15. Cost-effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage
- Author
-
Ailawadi, Monica, Lorch, Scott A., and Barnhart, Kurt T.
- Subjects
- *
ECTOPIC pregnancy , *PREGNANCY complications , *DILATATION & extraction abortion , *COST effectiveness - Abstract
Objective: To compare the cost and complication rate of two alternative strategies for the diagnosis and medical management of ectopic pregnancy when ultrasound is nondiagnostic. Design: A decision tree was constructed to compare [1] dilatation and curettage (D&C) followed by treatment of all ectopic pregnancies with methotrexate versus [2] empiric treatment of all patients with possible ectopic pregnancies with methotrexate without D&C. Setting: University setting. Patient(s): Ten thousand hypothetical women with nonviable pregnancies and a known incidence of ectopic pregnancy were entered into a computer model. Main outcome measure(s): The two approaches were compared with respect to the number of missed ectopic pregnancies, complications, procedures performed, admissions to the hospital, and cost. Result(s): The D&C group had 1% more failed managements of ectopic pregnancies and 13.4% fewer patients with a miscarriage undergo a second treatment for resolution. The D&C group had 13.7% fewer complications including 6.3% fewer hospitalizations. D&C costs $173 to $223 more than empiric use of methotrexate per patient. Conclusion(s): Empirically treating women at risk for ectopic pregnancy with methotrexate does not reduce complications or save money. In the absence of such savings, the desire to make an accurate and definitive diagnosis, allowing objective prognosis on future fertility and risk of repeat ectopic pregnancy, supports the need to distinguish a miscarriage from ectopic pregnancy before treatment with methotrexate. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
16. Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss.
- Author
-
Schreiber, Courtney A., Creinin, Mitchell D., Atrio, Jessica, Sonalkar, Sarita, Ratcliffe, Sarah J., and Barnhart, Kurt T.
- Subjects
- *
ABORTIFACIENTS , *COMBINATION drug therapy , *COMPARATIVE studies , *HUMAN embryology , *HEMORRHAGE , *RESEARCH methodology , *MEDICAL cooperation , *MIFEPRISTONE , *MISCARRIAGE , *ORAL drug administration , *PERINATAL death , *FIRST trimester of pregnancy , *RESEARCH , *RESEARCH funding , *ULTRASONIC imaging , *VAGINAL medication , *EMBRYOS , *EVALUATION research , *RANDOMIZED controlled trials , *MISOPROSTOL - Abstract
Background: Medical management of early pregnancy loss is an alternative to uterine aspiration, but standard medical treatment with misoprostol commonly results in treatment failure. We compared the efficacy and safety of pretreatment with mifepristone followed by treatment with misoprostol with the efficacy and safety of misoprostol use alone for the management of early pregnancy loss.Methods: We randomly assigned 300 women who had an anembryonic gestation or in whom embryonic or fetal death was confirmed to receive pretreatment with 200 mg of mifepristone, administered orally, followed by 800 μg of misoprostol, administered vaginally (mifepristone-pretreatment group), or 800 μg of misoprostol alone, administered vaginally (misoprostol-alone group). Participants returned 1 to 4 days after misoprostol use for evaluation, including ultrasound examination, by an investigator who was unaware of the treatment-group assignments. Women in whom the gestational sac was not expelled were offered expectant management, a second dose of misoprostol, or uterine aspiration. We followed all participants for 30 days after randomization. Our primary outcome was gestational sac expulsion with one dose of misoprostol by the first follow-up visit and no additional intervention within 30 days after treatment.Results: Complete expulsion after one dose of misoprostol occurred in 124 of 148 women (83.8%; 95% confidence interval [CI], 76.8 to 89.3) in the mifepristone-pretreatment group and in 100 of 149 women (67.1%; 95% CI, 59.0 to 74.6) in the misoprostol-alone group (relative risk, 1.25; 95% CI, 1.09 to 1.43). Uterine aspiration was performed less frequently in the mifepristone-pretreatment group than in the misoprostol-alone group (8.8% vs. 23.5%; relative risk, 0.37; 95% CI, 0.21 to 0.68). Bleeding that resulted in blood transfusion occurred in 2.0% of the women in the mifepristone-pretreatment group and in 0.7% of the women in the misoprostol-alone group (P=0.31); pelvic infection was diagnosed in 1.3% of the women in each group.Conclusions: Pretreatment with mifepristone followed by treatment with misoprostol resulted in a higher likelihood of successful management of first-trimester pregnancy loss than treatment with misoprostol alone. (Funded by the National Institute of Child Health and Human Development; PreFaiR ClinicalTrials.gov number, NCT02012491 .). [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
17. Following declining human chorionic gonadotropin values in pregnancies of unknown location: when is it safe to stop?
- Author
-
Cameron, Katherine E., Senapati, Suneeta, Sammel, Mary D., Chung, Karine, Takacs, Peter, Molinaro, Thomas, and Barnhart, Kurt T.
- Subjects
- *
CHORIONIC gonadotropins , *MISCARRIAGE , *ECTOPIC pregnancy , *UNIVERSITY hospitals , *RETROSPECTIVE studies , *ACADEMIC medical centers , *LONGITUDINAL method , *RESEARCH funding , *DIAGNOSIS - Abstract
Objective: To determine if the pattern of decline in hCG curves can discriminate spontaneous abortion (SAB) from ectopic pregnancy (EP).Design: Retrospective cohort study.Setting: University hospitals.Patient(s): A total of 1,551 women with symptomatic pregnancy of unknown location (PUL) and decreasing hCG values.Intervention(s): None.Main Outcome Measure(s): Percentage change in hCG; days and visits to final diagnosis.Result(s): Of the 1,551 women with a PUL and declining hCG, 146 were ultimately diagnosed with EP and 1,405 with SAB. An 85% hCG drop within 4 days or a 95% hCG drop within 7 days both ruled out an EP 100% of the time. Applying the 4-day cutoff to this population would have saved 16% of the SAB population (229/1,405) a total of 2,841 person-days and 277 clinical visits. Applying the 7-day cutoff would have saved 9% of the SAB population (126/1,405) a total of 1,294 person-days and 182 clinical visits. These cutoffs were separately validated on a group of 179 EPs collected from three university clinical centers. In that population, each cutoff separately ruled out EP 100% of the time.Conclusion(s): The decline in serum hCG is slower in EPs than in SAB and can be used to aid clinicians in the frequency and duration of follow-up. Costs and patient time may be saved by allowing women who meet one of these criteria to be followed less frequently. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
18. How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicity
- Author
-
Dillon, Katherine E., Sioulas, Vasileios D., Sammel, Mary D., Chung, Karine, Takacs, Peter, Shaunik, Alka, and Barnhart, Kurt T.
- Subjects
- *
CHORIONIC gonadotropins , *ECTOPIC pregnancy , *HEALTH outcome assessment , *MISCARRIAGE , *SYMPTOMS , *RETROSPECTIVE studies , *COHORT analysis - Abstract
Objective: To investigate the hCG profiles in a diverse patient group with ectopic pregnancy (EP) and to understand when they may mimic the curves of an intrauterine pregnancy (IUP) or spontaneous abortion (SAB). Design: Retrospective cohort study. Setting: Three university hospitals. Patient(s): One hundred seventy-nine women with symptomatic pregnancy of unknown location. Intervention(s): None. Main Outcome Measure(s): Slope of log hCG; days and visits to final diagnosis. Result(s): Of women with an EP, 60% initially exhibited an increase in hCG values, with a median slope of 32% increase in 2 days; 40% of subjects initially had an hCG decrease, with the median slope calculated as a 15% decline in 2 days. In total, the hCG curves in 27% of women diagnosed with EP resembled that of a growing IUP or SAB. Of the EP hCG curves, 16% demonstrated a change in the direction of the slope of the curve. This was more common in African Americans and less evident in Hispanics. Furthermore, it was associated with more clinical visits and days until final diagnosis. Conclusion(s): The rate of change in serial hCG values can be used to distinguish EP from an IUP or SAB in only 73% of cases. The number of women who had a change in direction of serial hCG values was associated with race and ethnicity. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
19. Perinatal morbidity after in vitro fertilization is lower with frozen embryo transfer
- Author
-
Kansal Kalra, Suleena, Ratcliffe, Sarah J., Milman, Lauren, Gracia, Clarisa R., Coutifaris, Christos, and Barnhart, Kurt T.
- Subjects
- *
HUMAN in vitro fertilization , *TREATMENT effectiveness , *HUMAN embryo transfer , *OVARIES , *NEONATAL diseases , *PREGNANCY , *LOGISTIC regression analysis , *FETAL growth retardation , *MISCARRIAGE , *CONCEPTION - Abstract
Objective: To study the association of perinatal outcome and IVF transfer type in a group of infertility patients with standardized treatment and similar prognosis.Design: Retrospective cohort study.Setting: University-based infertility center, January 1998 to June 2006.Patient(s): Two hundred eighteen IVF pregnancies after fresh embryo transfer (ET); 122 IVF pregnancies after frozen ET.Intervention(s): Assessment of perinatal outcome in fresh versus frozen ET pregnancies.Main Outcome Measure(s): Pregnancy outcomes after fresh versus frozen embryo transfer (ET). Primary outcome was a composite of three events: preterm delivery, intrauterine growth restriction, or low birth weight. Secondary outcomes were subtypes of pregnancy loss. Associations were assessed using multivariate logistic regression.Result(s): The final sample included 340 pregnancies: 218 fresh and 122 frozen ETs. Singleton pregnancy was less likely after transfer of fresh embryos (odds ratio [OR] 0.39, 95% confidence interval [CI] 0.23-0.67), and pregnancies after fresh ET were more likely to end in first-trimester loss (OR 1.82, 95% CI 1.05-3.13). Composite adverse outcome after transfer of fresh (44.0%) versus frozen (32.6%) embryos was higher (OR 1.52, 95% CI 0.90-2.56) and was strongly associated with twin gestation (OR 23.82, 95% CI 11.16-50.82).Conclusion(s): Perinatal morbidity is higher in IVF pregnancies conceived after a fresh ET compared with a frozen ET. Although some differences are related to conception with twin gestations, these findings suggest that adverse outcomes may be related to differences in IVF procedures. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
20. Application of redefined human chorionic gonadotropin curves for the diagnosis of women at risk for ectopic pregnancy
- Author
-
Seeber, Beata E., Sammel, Mary D., Guo, Wensheng, Zhou, Lan, Hummel, Amy, and Barnhart, Kurt T.
- Subjects
- *
PREGNANCY , *OBSTETRICS , *GONADOTROPIN , *ECTOPIC pregnancy - Abstract
Objective: To validate recently characterized curves of hCG rise and fall that are seen in viable and nonviable pregnancies in a population of women who have pregnancies of unknown location. Design: Historical cohort study. Setting: University hospital. Patient(s): One thousand two hundred forty-nine women with symptomatic early pregnancies. Intervention(s): None. Main Outcome Measure(s): Comparison of observed hCG values to predicted hCG values; time to diagnosis of ectopic pregnancy; accuracy of diagnosis. Result(s): Of the 1,249 patients included in this study, 196 had ectopic pregnancy (EP); 261, intrauterine pregnancy (IUP); and 792, spontaneous abortion (SAB). By determining the rate of change in hCG values from two consecutive visits and comparing them with a minimal rise of 35% in 2 days (the bound that is defined by the 99.9% confidence interval [CI] for the rise of hCG in an IUP) or a minimal fall of 21%–35% (the bound that is defined by the 90% CI for the fall of hCG in an SAB), we were able to make the diagnosis of EP an average of 2.5 days sooner than by standard clinical practice. Only 12% of patients had an EP go undiagnosed by using these rules, because the curve of rise or fall of their hCG mimicked that of a non-EP gestation. Conclusion(s): Recently redefined curves of rise and fall in hCG for IUP and SAB are valid for clinical use on the basis of our application to this large cohort of patients. Using them can shorten the time needed to make the diagnosis of EP. Use of a more conservative cutoff for minimal rise in hCG, one as slow as 35% over 2 days, to characterize a potentially viable gestation would minimize potential interruption of a desired pregnancy. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
21. Risk Factors for Spontaneous Abortion in Early Symptomatic First-Trimester Pregnancies.
- Author
-
Gracia, Clarisa R., Sammel, Mary D., Chittams, Jesse, Hummel, Amy C., Shaunik, Alka, and Barnhart, Kurt T.
- Subjects
- *
OBSTETRICS , *MISCARRIAGE , *ABORTION , *FIRST trimester of pregnancy , *DURATION of pregnancy - Abstract
OBJECTIVE: To evaluate the association of an ultimate diagnosis of miscarriage with various clinical symptoms and historical factors in a cohort of women presenting with pain, bleeding, or both in the first trimester of pregnancy. METHODS: This was a case-control study from a population of women presenting for care with pelvic pain or vaginal bleeding in the first trimester of pregnancy whose diagnoses were not definite upon initial evaluation. Analyses were performed in 2 ways. In one instance cases were defined as women ultimately definitively diagnosed with a miscarriage and controls were defined as women with a pregnancy that did not result in miscarriage (ectopic pregnancy or ongoing intrauterine pregnancy). The second analysis compared women with a miscarriage only to women who had an ongoing intrauterine pregnancy. RESULTS: A total of 2,026 women were evaluated, with 1,192 ultimately diagnosed with a spontaneous abortion, 367 with ectopic pregnancy, and 467 with a viable intrauterine pregnancy. Although many risk factors were individually associated with miscarriage in preliminary analysis, in the final analysis only extremes in age (« 25 and » 35) and the complaint of bleeding (odds ratio [OR] 7.35, 95% confidence interval[CI] 5.74–9.41) were associated with miscarriage. The complaint of pain (OR 0.72, 95% CI 0.57–0.92), human chorionic gonadotropin (hCG) value greater than 500 (hCG ≤ 500 IU/mL compared with hCG 501–2000: OR 0.52, 95% CI 0.39–0.69) and concurrent cervical infection (OR 0.69, 95% CI 0.55–0.88) were negatively associated with miscarriage. CONCLUSION: Few factors predict miscarriage in women who present with a symptomatic first trimester pregnancy of unknown location. Heavy bleeding was most strongly associated with miscarriage. Concurrent cervical infections should not be overlooked as a cause of bleeding in early pregnancy and were not associated with miscarriage. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
22. Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy.
- Author
-
Sullivan-Pyke, Chantae, Haisenleder, Daniel J, Senapati, Suneeta, Nicolais, Olivia, Eisenberg, Esther, Sammel, Mary D, and Barnhart, Kurt T
- Abstract
Objective: To validate the ability of serum kisspeptin-54 to discriminate between first-trimester viable pregnancies and miscarriages.Design: Case-control study.Setting: Academic medical centers.Patient(s): Women with confirmed viable intrauterine pregnancy (IUP) at estimated gestational age 6-10 weeks (n = 20), women with confirmed miscarriage (spontaneous abortion [SAB]) at estimated gestational age 6-10 weeks (n = 20), and nonpregnant women (n = 19).Intervention(s): Collection of serum samples from women with confirmed IUP, SAB, and nonpregnant women for the measurement of serum kisspeptin and serum hCG levels.Main Outcome Measure(s): Serum kisspeptin and hCG.Result(s): The limit of detection was 0.024 ng/mL; intra- and interassay coefficients of variation were 5.1% and 8.6%, respectively. Kisspeptin levels differed between the pregnant and nonpregnant state and by viability. Kisspeptin levels were positively associated with gestational age. There was also a significant positive association with hCG in SAB, but not in IUP.Conclusion(s): Plasma levels of kisspeptin have been suggested as a biomarker for miscarriage. This study demonstrates kisspeptin assay stability in serum and its potential clinical utility as a biomarker for early pregnancy viability. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
23. Predicting first trimester pregnancy outcome: derivation of a multiple marker test.
- Author
-
Senapati, Suneeta, Sammel, Mary D., Butts, Samantha F., Takacs, Peter, Chung, Karine, and Barnhart, Kurt T.
- Subjects
- *
FIRST trimester of pregnancy , *BIOMARKERS , *PROGESTERONE , *GESTATIONAL age , *COHORT analysis , *ENZYME-linked immunosorbent assay , *COMPARATIVE studies , *ECTOPIC pregnancy , *IMMUNOASSAY , *RESEARCH methodology , *EVALUATION of medical care , *MEDICAL cooperation , *MISCARRIAGE , *PEPTIDE hormones , *PHARMACOKINETICS , *PREGNANCY , *PREGNANCY proteins , *RESEARCH , *RESEARCH funding , *EVALUATION research , *PREDICTIVE tests , *CASE-control method , *RECEIVER operating characteristic curves , *DIAGNOSIS ,RESEARCH evaluation - Abstract
Objective: To predict first trimester pregnancy outcome using biomarkers in a multicenter cohort.Design: Case-control study.Setting: Three academic centers.Patient(s): Women with pain and bleeding in early pregnancy.Intervention(s): Sera from women who were 5-12 weeks' gestational age with ectopic pregnancy (EP), viable intrauterine pregnancy (IUP), and miscarriage/spontaneous abortion (SAB) was analyzed by ELISA and immunoassay for activin A, inhibin A, P, A Disintegrin And Metalloprotease-12, pregnancy-associated plasma protein A (PAPP-A), pregnancy specific B1-glycoprotein (SP1), placental-like growth factor, vascular endothelial growth factor, glycodelin (Glyc), and hCG. Classification trees were developed to optimize sensitivity/specificity for pregnancy location and viability.Main Outcome Measure(s): Area under receiver operating characteristic curve, sensitivity, specificity, and accuracy of first trimester pregnancy outcome.Result(s): In 230 pregnancies, the combination of trees to maximize sensitivity and specificity resulted in 73% specificity (95% confidence interval (CI) 0.65-0.80) and 31% sensitivity (95% CI 0.21-0.43) for viability. Similar methods had 21% sensitivity (95% CI 0.12-0.32) and 33% specificity (95% CI 0.26-0.41) for location. Activin A, Glyc, and A Disintegrin And Metalloprotease-12 definitively classified pregnancy location in 29% of the sample with 100% accuracy for EP. Progesterone and PAPP-A classified the viability in 61% of the sample with 94% accuracy.Conclusion(s): Multiple marker panels can distinguish pregnancy location and viability in a subset of women at risk for early pregnancy complications. This strategy of combining markers to maximize sensitivity and specificity results in high accuracy in a subset of subjects. Activin A, ADAM12, and Glyc are the most promising markers for pregnancy location; P and PAPP-A for viability. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.